AUTH/3482/3/21 - Complainant v GlaxoSmithKline

Alleged promotion of Nucala (mepolizumab) on LinkedIn

  • Received
    04 March 2022
  • Case number
    AUTH/3482/3/21
  • Status
    No breach, outwith the scope of the Code

Case Summary